| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_571b8abacacea64d3f7089d0983b8b3b |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
1994-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1995-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2ed89a17696764eb89e3747bb452f83
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36d447bb57ea3b6050af79966af402fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64bab70dd0497cfe84cc3801ad4654de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_241aaed21176a2c77a0af242dce7230a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48a0ed9d4d32fdb0b2a2624cde04243e |
| publicationDate |
1995-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-1336821-C |
| titleOfInvention |
Therapeutic nucleosides |
| abstract |
5-Chloro-1-(2,3-dideoxy-3-fluoro-.beta.-D-erythro-pentofuranosyl)uracil of formula (I): (I) and pharmaceutically acceptable derivatives thereof have potent antiviral activity particularly against Human Immunodeficiency Virus (HIV). |
| priorityDate |
1987-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |